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At JM we are utilising our scientifi c and 
manufacturing expertise to develop 
and commercialise ultra-pure synthetic 
cannabinoids that meet the quality 
requirements demanded by the
pharmaceutical industry. Our novel US 
DMF-validated process produces a free-
fl owing crystalline powder that is particle 
size adjustable, making it useful in a 
variety of drug product formulations.





eptember has always felt like a new start to me. Maybe 
because it marks the beginning of the academic 
year; the memory of sharpened pencils and starched 
uniforms. Perhaps it’s the change in the seasons; the 
promise of crisp Autumn mornings, with their colorful flurries 
of leaves. Or maybe it just the feeling that with only four 
months to go, the year is racing by and I’m running out of 
chances to catch it. 
Whatever your feelings, September is undeniably a time for change 
– and I can already see it happening politically. Just this week, Italy 
decriminalized the cultivation of cannabis plants for personal use, 
within days of Panama legalizing medical cannabis thanks to the 
tireless efforts of advocates like Sandra Carrillo. It is rumored that 
Mexico will follow suit in the weeks to come.
But not all change is good. Cannabis cultivators in Colorado are 
being told  to prepare for what could be another year of unseasonable 
cold spells – snowstorms and freezes – as their counterparts on the 
West Coast paradoxically struggle to protect their crops against 
drought and wildfires. (Last year, California’s historic fire season 
saw 4.2 million acres burn.)
Climate change is causing more extreme, unpredictable weather 
– and outdoor cultivators are bearing the burden. But where does 
cannabis as a whole fit into the sustainability debate? Are we doing 
enough as an industry to meet the demands of our rapidly changing 
world? As our feature (The Cannabis Carbon Bomb, page 16) on 
the emissions associated with indoor cultivation shows, the answer 
(for now, at least) is no. Indoor-grown cannabis is many things, but 
“green” it is not.  
Of course, the conversation surrounding sustainability – 
particularly in regards to cultivation, with all the policies and politics 
that govern it – is too nuanced to be condensed into any single feature, 
and certainly any editorial. We plan on continuing this discussion 
in the future, so if you have anything to say, please reach out – we 
want to hear from you.
Until then, let’s focus on the positive. Every day cannabis makes 
new strides in science, medicine, and politics, advancing our 
understanding and opening access to this most wonderful of plants. 
As for the rest? If we know anything, it’s that change is going to come, 
whether you like it or not – all you can do is be ready.
Phoebe Harkin
Deputy Editor
Wake Me Up When September Ends
The most tempestuous of seasons is already making its mark  
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Marijuana appears to have 
detrimental effect on  
semen quality
6 Upfront
Marijuana is good for many things but, as 
it turns out, maintaining fertility isn’t one 
of them. Researchers have noticed that 
marijuana use is common among men 
presenting for fertility evaluation and 
may have a detrimental effect on semen 
quality, particularly morphology and 
volume. Confusingly, though, it may also 
be protective against abnormal sperm 
motility. So what are we to believe? In a 
daring evaluation, researchers have taken 
a closer look at this at-risk population by 
assessing the semen of 409 current, past, 
and “never-users” (1).
Compared with never-users, current 
and past users had a significantly higher 
likelihood of abnormal sperm strict 
morphology (33.1 percent versus 50.7 
and 53.4 percent, respectively). However, 
sperm motility was more likely to be 
below average in never-users than in 
current and past-users (38.3 percent 
versus 21.1 and 27.2 percent). Upon 
analyses, current use was associated 
with increased odds of abnormal strict 
morphology and semen volume less than 
WHO reference value, whereas below-
average sperm motility was reduced.
We asked lead author Omer Raheem, 
Assistant Professor of Urology at Tulane 
University School of Medicine, USA, if 
he was surprised there wasn’t a bigger 
difference between current and past 
users. “One would expect and hope that 
past smokers would have better sperm 
morphology since discontinuation of 
marijuana smoking; however, it remains 
unknown how long it takes to recover 
sperm morphology after discontinuation 
of marijuana smoking.”
Interestingly, despite most sperm 
parameters’ being affected by marijuana 
use (potentially signaling the negative 
impact of spermatogenesis and testicular 
function overall), Raheem would not 
advise men against cannabis if they 
want a child – but he does offer a word of 
caution. “Although marijuana use can be 
helpful in some medical conditions, such 
as chronic pain, it has a negative impact 
on men’s reproductive ability and may 
render them infertile for a long time. 
Having said this, given the paucity of 
quality data investigating the full effect 
of marijuana on men’s health, a larger 
study is urgently needed to evaluate 
these findings.” So now you know. Stay 
safe out there, guys.
Reference
1. M Hehemann et al., Ther Adv Urol, 13 (2021). 
PMID: 34367341
This or That
Global policy shifts have 
seen a rise in the number of 
cannabis as medicine (CaM) 
users globally. Here’s what  
we know so far.





SUBSTITUTION users  
are more likely to be women 
and to use CaM in the 
treatment of CHRONIC 
PAIN and other somatic  
conditions (1). 
Pain medication  
(67.2 percent), 
antidepressants  
(24.5 percent), and  
arthritis medication  
(20.7 percent) are the most 
common types of drugs 
replaced with CaM. 
The latest industry news –  
in 60 words or less 
• Grow Group has raised £3.4 
million in Europe’s largest-ever 
medical cannabis crowdfunding 
venture following the acquisition 
of a production facility in 
Andalusia, Spain. The fundraiser 
– the highest amount raised by 
any cannabis firm on the Seedrs 
platform – will be used to expand 
operations throughout Europe 
and propel R&D programs. 
• The Nevada Cannabis 
Compliance Board issued 
a summary suspension of 
cultivation license for Green 
Cross of America. Board 
members voted unanimously to 
suspend the firm after agents 
found more than 400 plants not 
tracked in the state’s seed-to-sale 
system, citing present threat to 
public health and safety.
• Alabama’s medical cannabis 
program might roll out slower 
than expected. The state’s 
agriculture department suggests 
that cultivation licenses will be 
issued no earlier than September 
2022. Taking into account 
marijuana’s cultivation cycle, this 
means licensed product won’t be 
ready for sale until the following 
year.
• A Massachusetts firm has been 
ordered to pay US$300,000 
for inadequately compensating 
employees for working Sundays 
and holidays – a stark reminder 
that cannabis operators must 
abide by nuances of states’ hourly 
wage provisions. In this case, 
labor law states that “premium 
pay” is 1.2 times the usual rate. 
The company put the issue down 
to “inadvertent payroll errors.”
• The smokable hemp ban has 
been removed from California’s 
contentious AB-45 bill, which 
heads to final vote next week. If 
passed, ingestible CBD products 
will be legal, as will the addition 
of cannabinoids and other hemp 
extracts to dietary supplements, 
food, beverages, cosmetics, 
and pet food – all currently 
prohibited.
References are available online
 B U S I N E S S  I N  B R I E F 
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1. S Kvamme et al., 
Harm Reduct J, 
18, 72 (2021). 
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Do No Harm 
Could CBD reduce common 
cannabis side effects?
A novel study has examined the 
differential effects of various THC:CBD 
ratios, using widely available chemovars 
(1). The team assessed 159 regular 
cannabis users before, immediately 
after, and one hour after ad libitum 
administration of one of three randomly 
assigned cannabis flower chemovars: 
THC-dominant (24% THC, 1% CBD), 
THC+CBD (9% THC, 10% CBD), 
and CBD-dominant (1% THC, 23% 
CBD). Plasma cannabinoids, as well 
as positive (high, elation) and negative 
(paranoia and anxiety) subjective effects 
were measured at each time point. 
As expected, researchers found 
that participants who used the 
CBD-dominant and THC + CBD 
chemovars had significantly less THC 
and more CBD in plasma samples 
than participants who used the THC-
dominant chemovar. More interestingly, 
the THC + CBD chemovar group was 
associated with similar levels of positive 
subjective effects as the THC-dominant 
chemovar – but, crucially, with 
significantly less paranoia and anxiety.
 
References
1. L Gibson et al., Addict Biol (2021). Online ahead 
of print. Available at: https://bit.ly/3kWe2Cd 
Among substitution  
users, 38.1 percent report 
termination of prescription 
drug use, and 45.9 percent 
a substantial decrease  
in prescription  
drug use. 
Promisingly, 65.8 percent  
find CaM much more 
effective than prescription 
drugs, with 85.5 percent 
claiming the side effects 
associated with prescription 
drug use are much worse 
than those associated with 
cannabis use. 
8 Upfront
Despite more and more attention given to 
the toxicology of cannabis contaminants, 
there is still no federal regulation to 
standardize testing or residue limits. With 
countless products recalled for reports of 
questionable pesticide levels, the question 
remains: how safe is medical cannabis? To 
find out if cannabis represents a potential 
route of pesticide exposure to susceptible 
populations, US researchers compared 
a number of qualifying neurological 
conditions against cannabis pesticide 
testing requirements in 33 states and 
Washington DC. 
The team found that movement 
disorders (including epilepsy, multiple 
sclerosis, and Parkinson’s Disease) are 
the most common neurological category 
of qualifying conditions in the country. 
They also discovered that the number 
and action levels of regulated pesticides 
in cannabis varied significantly across 
the US; for example, six states imposed 
the strictest residue limits for food 
commodities on up to 400 pesticidal 
active ingredients in cannabis, while three 
states (worryingly) considered pesticides 
testing “optional.” Of all the pesticides 
examined, dimethomorph, a fungicide 
effective against various pathogens in 
vines and other crops, showed the largest 
variation in action levels, ranging from 
0.1 to 60 ppm in five states. So, what 
impact do these fluctuations have – if 
any – on a functional level? 
The team used the Comparative 
Toxicogenomics Database to identify any 
possible connections with insecticides, 
cannabinoids, and seizure, and found 
that 22 insecticides, two cannabinoids, 
and 63 genes were associated with 674 
“computationally generated chemical-
gene-phenotype-disease tetramer 
constructs.” Cholinergic, dopaminergic, 
and retrograde endocannabinoid 
signaling pathways were linked to 10 
genetic variants of epilepsy patients.
The study authors conclude that medical 
use of cannabis could unintentionally 
expose susceptible patients to harmful 
pesticides, contaminants, and 
cannabinoids that disrupt the same 
signaling pathways that have links with 
seizure disorders. The team has called 
for further research to fully establish 
any potential hazards, with the hope 
of informing a national standard for 
acceptable cannabis pesticide limits. 
Considering the implications for an 
already vulnerable population, let’s hope 
they are successful. 
Reference
1. D Pinkhasova et al., Curr Res Toxicol, 2, 140, 
PMID: 34308371
Warning:  
Risk of Residue 
Researchers investigate 
a potential link between 
pesticide residue and 
neurological disease
It is well reported that people with HIV 
(PWH) use cannabis at a higher rate than 
the general population, but relatively little 
is known about its influence on neural 
activity in PWH. Researchers set out to 
quantify the impact of chronic cannabis use 
on brain and cognitive function through 
magnetoencephalographic brain imaging 
data. The study split 81 participants across 
four demographically matched groups 
(PWH using cannabis, controls using 
cannabis, non-using PWH, and non-using 
controls) and asked them to complete a 
visuospatial processing task. They found 
PWH exhibited significant behavioral 
deficits in visuospatial processing, as 
well as reduced theta oscillations 
and elevated pre-stimulus 
gamma activity in visual 
cortices. Strikingly, chronic cannabis use 
was associated with a significant reduction 
in pre-stimulus gamma activity in the visual 
cortices – so much so that PWH no longer 
statistically differed from controls, providing 
evidence that cannabis use may normalize 
some neural aberrations in PWH.
 
Reference
1. N Christopher-Hayes et al., Hum Brain 
Mapp (2021). Online ahead of print. 
Available at: https://bit.
ly/38MmGgU 
New Hope for HIV 
Cannabis has normalizing 
effect on pre-stimulus gamma 
activity in PWH
Up In Smoke
More than 650 million dollar’s  worth of drugs, including heroin, cannabis, 
methamphetamine, and ketamine, were burned by Myanmar’s military authorities 
in a hardline attempt to stop industrial production. The haul was set ablaze on the 
United Nations International Day against Drug Abuse and Illicit Trafficking.
 
Credit: Associated Press
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Q U O T E  o f  t h e  m o n t h
“The cultivation of hemp at home is essential for patients who have to make 
therapeutic use of it and who often do not find it available, as well as 
[combating its] sale and consequent criminal undergrowth."
Mario Perantoni 
President of Italy’s Chamber’s Justice Commission, as Italy votes to 
decriminalize small-scale cultivation of cannabis plants.
 I M A G E  O F  T H E  M O N T H 
Cannabis use is increasing among 
adults, but though evidence connects 
cannabis use to poor periodontal 
health, few prospective studies 
exist in the US to prove it. A recent 
investigation examined associations 
between cannabis use and self-reported 
adverse oral health conditions among 
almost 19,000 participants as part of a 
nationwide Population Assessment of 
Tobacco and Health (PATH) Study. 
Reported cannabis use was positively 
and prospectively associated with 
multiple measures of poor oral health, 
including a number of conditions 
(gum bleeding, loose teeth, alveolar 
bone loss and gum disease) indicative 
of periodontitis. 
The study’s authors acknowledged 
that limited information on frequency 
and modality of cannabis use, but 
nevertheless came to a strong conclusion. 
Compared with participants who 
had never used cannabis, those who 
consistently reported recent cannabis 
use over a three-year period had 
nearly double the odds of subsequently 
reporting poor or fair overall oral 
health, gum bleeding and loose teeth, 
even after statistical adjustment for 
sociodemographic, socioeconomic, 
and behavioral risk factors, such as 
tobacco smoking. 
Reference
1. B Chaffee, J Calif Dent Associ, 49, 493 
(2021). PMID: 8415705
9Upfront
Grin and Bear It 
PATH study associates 
cannabis use with increased 
risk of poor oral health
Around the world, legal medicinal and 
recreational cannabis use is growing 
rapidly. A global trend that has continued 
to rise despite the COVID-19 pandemic, 
especially in the US, where states and 
territories with legal cannabis markets 
deemed the sector an essential industry. 
But it has not all been plain sailing.
The pandemic has fueled staffing 
challenges in cannabis testing, with labs 
struggling to find the skilled staff that 
they need. This and the desire for the 
industry to break into new geographies 
and market segments at the same time, 
is also leading to the need for more 
intuitive technologies to ensure reliable 
testing and analysis which is vital for 
providing processors with confidence 
in their developing supply chains.
The cannabis industry is no stranger 
to innovative testing technologies but, 
especially for a young field struggling 
with human resources, automated 
analysis appears to be a clear front 
runner in helping meet the challenges 
and opportunities within the growing 
sector. With sensitive, accurate and 
easy-to-use semi- or fully- automated 
testing technologies, labs and 
processors are able to meet regulatory 
and customer demands without the 
need to source scores of highly trained 
scientists and operators.
Automated mycotoxin and pesticide 
testing solutions provide streamlined 
sample prep, increased throughput, 
decreased cost per sample and feature 
“set it and forget it” functionality for 
all stages of the testing workflow. 
Prebuilt cannabis analysis methods 
that have been optimized for leading 
state regulations can also be used in 
concert to help increase efficiency and 
reproducibility, all while decreasing time 
and resource requirements.
In addition to the technology itself, 
cannabis testing can also generate a lot 
of data. With manual analysis proving 
both laborious and training-intensive, 
automated systems can help deliver 
accurate and consistent results to clients 
or relevant regulatory frameworks. 
Combining easy-to-use automated 
systems with powerful yet intuitive 
software can help ensure that the 
right data is easily collected, accessed, 
analyzed, and accurately reported.
10 In My V iew
Green Machine
Why automated testing 
technologies could take the 
cannabis market to the  
next level
By Toby Astill, Global Market Manager for 
Cannabis and Hemp at PerkinElmer, Inc.
 In My 
View
Experts from across the 
world share a single 








per sample for 
all stages of 
the workflow.”
Additionally, ensuring any implemented 
software is open-source, the ability to 
connect and rapidly analyze data from 
multiple, varied instruments, will further 
simplify analysis. Such benefits will 
help labs future-proof their efforts 
against growing sample volumes and 
regulatory demands as the industry 
continues its rapid expansion into the 
food and beverage sector.
So, what now? I’d argue that the ever-
expanding cannabis market requires 
automated workflows on an open-source 
platform to help accommodate any future 
pesticide or mycotoxin targets that might 
be added to state or country regulations 
as producers work to keep pace. In my 
mind, education around regulations and 
best practices for implementing the newest 
generation of automated cannabis testing 
technologies is a great place to start.
But regardless of how the cannabis 
industry evolves and the regulations in 
this industry change, automation has the 
potential to allow the industry to not only 
keep up with demand, but also to advance, 
innovate, and thrive.





Is Africa getting short-
changed on its own 
resources by foreign 
cannabis companies?
By Louisa Mojela, Chairman of the 
Halo Collective and Founder of Bophelo 
Bioscience, Lesotho
Cheap labour + cheap materials = low 
costs and high profit margins. It’s the 
equation that every business strives to 
master. The problem is that those profit 
margins often come at a cost to emerging 
markets that are seeking growth and 
investment. For the cannabis industry, 
it makes sense to produce products in 
Africa, where the growing conditions 
are ideal and production and labor 
costs are lower. But that opportunity 
should be matched by a certain amount 
of responsibility. And that’s something 
we know all too well at Halo Collective.
We’re a US-based company that 
specializes in modern cannabis extraction 
techniques and cannabinoid isolation. 
Owner of the largest grow sites in North 
America, Halo uses proprietary techniques 
and leading-edge technology to develop 
innovative products. And with the cannabis 
industry booming, the time is ripe to expand 
both vertically and into new markets… But 
we also understand the active role cannabis 
can play in transforming the economies of 
developing nations.
We acquired Bophelo Bioscience and 
Wellness in Lesotho in 2020. Bophelo 
is currently operating in a five-hectare 
facility – with access to an additional 200 
hectares – and it will soon be the largest 
cultivation site in the world. The conditions 
are close to perfect for a cannabis business: 
the environment is pristine, there is plenty 
of water and sunshine, energy costs are low, 
and labor is competitively priced. All that 
is needed is foreign investment and the 
technical and business skills to maximize 
this opportunity for the country. 
My family is from the Mafeteng district 
of Lesotho, where Bophelo Bioscience 
is situated, so I know well the struggles 
that Lesotho faces. About 40 percent of 
the country’s population live below the 
poverty line, with many just getting by 
on subsistence farming. Unemployment 
has left many with no choice but to 
leave and find work in South Africa. 
As a country, the challenges faced 
are manifold, but we continue to work 
towards growth and development.
Lesotho was the first country in Africa 
to legalize the cultivation and manufacture 
of medical cannabis. In fact, cannabis has 
been used as medicine by the local Basotho 
people for many years. As a result, they 
already have expertise in cultivating it 
– experience that will stand Lesotho in 
good stead as it enters the global cannabis 
market via Halo. 
Halo’s commitment to taking care of 
and developing existing resources and the 
community in which we operate runs deep. 
Our vision is to create opportunities for 
generations of local people, establishing 
a positive work environment where 
employees can earn more than the 
government-regulated minimum wage, 
thus raising their standard of living. We 
practice equal opportunity employment, 
with compensation based not only on 
labor laws, but on merit, qualifications, 
and individual abilities. As a local to 
Lesotho, I also see the importance of 
offering our employees career and training 
opportunities, teaching skill sets that can 
empower people on the ground to rise 
within our company, rather than bringing 
in outside hires.
When the acquisition of Bophelo was 
finalized, one of Halo’s first priorities was 
to pledge 10 percent of pre-tax profits to 
community causes in the Tsakholo (the 
site of operations), as well as the greater 
Mafeteng area. Halo does this through the 
Mophuthi Matsoso Development Trust, 
which I founded in 2010. The Trust is 
12 In My V iew
dedicated to rural community development 
for those in need, especially women and 
children, and aims to address poverty and 
build self-reliance. 
The goals of Mophuthi Matsoso are 
threefold: to fund education, especially 
early learning; to empower women through 
projects and programs that develop skills, 
build capacity and help to generate cash; 
and to invest in agriculture to fight hunger 
and promote food security. 
In line with these goals, Mophuthi 
Matsoso has upgraded several local schools 
from dilapidated old buildings, adding 
electricity, ablution facilities, staff offices, 
and libraries. The Trust has also built a 
learning center that is fully electrified and 
equipped with a science and mathematics 
lab, a computer center, sports facilities, and 
a library. These top-class learning facilities, 
along with well trained teachers, will equip 
local children for future careers that can 
further benefit the country.
Funds from the Trust have also been 
used to purchase farming equipment and 
plough community fields at no cost, and 
to set up a project where pigs are raised 
for food and for market. The badly eroded 
roads in the area are being upgraded so 
locals can more easily transport goods and 
reach towns, schools and clinics. And the 
newly-built All Saints Anglican Church 
will help anchor the community and 
provide for their spiritual needs.
It’s my belief that the success of a 
company must be measured by the 
development of the community around it 
– communities (women and young people 
in particular) cannot be left impoverished 
whilst companies thrive at their exclusion. 
Ultimately, our goal is not just to succeed 
in our business in Lesotho, but also to 
invest in the people who contribute to 




How a lack of training is 
dissuading patients – and 
healthcare professionals 
– from the benefits of 
traditional herbal medicine
By Sukvinder Kaur Bhamra, Lecturer 
in Pharmacy Clinical and Professional 
Practice at the Medway School of 
Pharmacy University of Kent, UK
Social media’s impact on the popularity of 
“natural” products has been significant – 
and CBD is far from the exception to the 
rule. The increased demand in sales and 
supply of herbal remedies over the past 
few years is an example of how people are 
starting to reconsider natural products. I 
like to think that they are “coming back 
into fashion.”
I recently published a paper surveying 
public perception of CBD globally. A 
wide range of responses were recorded, 
including some in favor and others sceptical 
of the use of CBD. Some participants 
reported a willingness to try CBD products 
because they were seeking a more holistic 
lifestyle or because of promotions they 
had seen on social media; others shared 
concerns about the lack of regulation of 
CBD products, especially as they were 
often sold as food supplements and not 
medicines. The need for more research 
and evidence to demonstrate the safety 
and efficacy of CBD was highlighted (1).
Naturally, we asked an important 
question: is lack of clinical evidence on 
safety and efficacy actually deterring use? 
For some people, the answer was yes. If 
there was more information to facilitate the 
safe use of CBD based products it would be 
well received. Improved clinical evidence is 
not only required for users/the public, but 
also healthcare professionals, who do not 
have sufficient knowledge of how herbals 
interact with conventional medicines so 
often advise against their use. On the 
other hand, those who are interested in 
natural products – based on traditional 
use – will not be affected by the lack of 
clinical evidence. 
It is important to remember that natural 
products were being used long before 
conventional medicines were developed. 
Certainly, many talented and inventive 
people are responsible for the advances 
that make up modern medicine. But, as 
a society, I feel we have become so driven 
by evidence-based medicine, guidelines, 
and accountability that our freedom 
to explore natural products has been 
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restricted. Where once nature provided 
well-known remedies, we now rely entirely 
on pharmaceutical intervention.
There are three reasons behind this 
almost complete shift away from natural 
products. The first is access; those products 
that are native to some countries are not 
always easy to find in others – tulsi (also 
known as holy basil, Ocimum tenuiflorum 
L.) is an example of this. Closely related 
to basil, tulsi has been used for various 
ailments, including asthma, eczema, and 
diabetes, in Southeast Asia. Here in the 
UK, tulsi is less common, but seeds are now 
exchanged within communities who have 
found ways of successfully growing this 
native Indian plant (2).
The second reason is cost. It is only 
with the introduction of the National 
Health Service (NHS) and free access to 
healthcare for all that people began seeking 
medical advice and with it, a prescription, 
as opposed to seeking a natural solution. 
With standardized dosing, formulations 
and prescribing guidelines, we have seen 
a transition away from nature’s pharmacy 
and instead, a reliance upon cheaper (or 
free) mass-produced medicines.
The third reason is knowledge – or lack 
thereof. Often, healthcare professions 
disregard the use of natural products 
– even going as far as to advise patients 
against their use, because of unknown 
herb-drug interactions (3). If we don’t fully 
understand the pharmacological effects of 
natural products – and if the evidence base 
and clinical guidelines are lacking – it’s a 
clear problem.
As a healthcare professional, I had 
very limited training on natural products 
during my undergraduate training. Now, 
as an academic training the next generation 
of healthcare professionals, I can see the 
problem still exists. The answer is simple 
in theory, but difficult in practice. We 
need better education for healthcare 
professionals and the public, more clinical 
evidence, and better regulation surrounding 
natural products. Only by addressing all 
three areas will we see traditional and 
conventional medicines used in a safe and 
effective manner.  
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There are plenty of anecdotes from 
dissatisfied patients who fail to find the same 
relief from one batch of cannabis to the next. 
There are likely even more stories of adult-
use consumers questioning the provenance 
or identity of their purchase. 
But when it comes to research – where 
cannabis origin and processing should (at 
least in theory) be guaranteed – have we 
placed enough emphasis on controlling what 
happens from the harvest to the lab? 
Here, we explore how product stability 
is affecting patients, the industry – and, in 
particular, cannabis scientists who are keen to 
eliminate all sources of potential variation to 
publish the best, most reproducible research.
(Good) Practice Makes Perfect
By Andrew Samann CEO,  
Orion GMP Solutions
Cannabis is a living organism with complex 
systems designed to protect it against the 
environment and pathogens. When it is 
cut, preservation requires careful handling. 
Preservation directly relates to quality (see 
box “GMP 101”), which is dependent on 
some basic facts. How much time has 
passed between cutting and storing? How 
quickly was the cannabis processed? How 
was it dried? In short, the key to quality 
cannabis is adequate preservation–and that 
demands water activity testing.
When it comes to cannabis drying, some 
prefer to hang dry, others prefer to cut the 
buds down and dry on trays; in any scenario, 
measuring the rate of evaporation is critical – 
and this can only really be measured via water 
activity is the relative humidity immediately 
adjacent to the product vs the total moisture 
in the plant. Indeed, the impact of the drying 
process can only be understood by precisely 
measuring water activity in any drying case 
(from fastest or slowest) and relating drying 
rate to product quality. Product quality 
may be assessed by water activity, as well 
as, shape, odor, bud size, color, et al. These 
critical quality attributes (CQAs) determine 
if a cannabis sample is well preserved and of 
high quality. Optimizing CQAs for the drying 
process provides growers the guidelines they 
need to  sustain the quality of their flower.  
Preserve and protect
So why is preservation such a big deal? In 
Canada, as in many places around the world, 
more cannabis is grown than consumed. 
Overproduction results in surplus. This 
aged inventory may not be safe to consume, 
which results in companies having no choice 
but to destroy product. As an industry, we 
still haven’t worked out the critical control 
point between packaging and long-term 
shelf life–but it’s time we do so. 
Recent global circumstances that caused 
retail closures and shipping delays illustrate 
why we must protect product throughout 
the supply chain. Contrary to past belief, we 
have little control over how long cannabis 
will sit on the dock or the shelf. There are 
no cannabis-specific guidelines for packaging 
and humidity control. Cannabis professionals, 
therefore, implement GMPs by interpreting 
scientific literature then relating it to the 
specific needs of their cultivars and extracts. 
Understanding how water relates to that is 
more fundamental than people understand.
Currently, Orion GMP is overseeing a 
stability study assessing the performance 
of salt solution-based humidity control 
sachets, which are designed to protect 
active ingredients in cannabis flower from 
evaporation and degradation. These 
saturated salt solution sachets are engineered 
to create a microclimate with the optimum 
level of humidity for sample preservation. 
The goal of the study is to establish cannabis 
shelf life guidelines for various packaging 
component systems.
For pharmaceuticals, there are two main 
types of containers – impermeable and 
permeable. This stability study will go beyond 
those, using multiple packaging types, including 
impermeable,  permeable and experimental 
containers as well as a control group. We will 
measure the performance of the sachets in 
multiple configurations of a packaging system 
to establish legitimate shelf-life claims.
Not only will we ascertain stability 
immediately after the flower is dried and 
cured, but how it responds over time –
particularly in fluctuating environments. That 
means studying flower with and without a 
sachet through every step of the supply 
chain –from harvest to the point of delivery, 
including international distribution.
Dead on Arrival?
Why guaranteed product shelf 
life may be the most critical 
component of cannabis research
 Sponsor d Feature
GMP 101
I am often asked: What is the value of 
good manufacturing practice (GMP)? 
A better question is: What is the cost 
of quality? How much does a recall 
or regulatory infraction cost? hen 
you consider the potential contracts 
lost as a result of any breach, the 
cost of quality becomes even more 
significant. You can put a number on 
the financial burden of not meeting 
FDA requirements, but what about the 
impact of a spoiled scientific sample? 
It’s certainly less tangible but no less 
important for the customers of those 
products–researchers.
GMP essentially improves product 
quality through the naming of 
specifications. What goes into the 
product? Is it safe? Is the facility clean? 
Does it meet certain standards? Are 
staff sufficiently trained? Each and every 
aspect contributes towards a quality 
management system. But when it comes 
to cannabis flower the ultimate control 
points arguably happen post-harvest.
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Though there are plenty of people working 
on stability for their own products, this will 
be the first time a packaging component 
system has been studied outside of a 
single company or brand. How exciting 
would it be to offer a universal solution, 
where a single sachet could offer a 
defined, extended shelf life to anyone, 
anywhere? We don’t have the answer 
yet, but we will in time. 
The cost is too great not to.
Save the Terps – Reprise!
An interview with Dr. Cindy S. Orser,  
CSO Clip Labs
Why are terpenes so important in our 
understanding of the cannabis plant?
Terpenes represent a large, diverse category 
of pharmacologically active chemicals made 
by animals, insects, microbes, and plants, 
including cannabis. Terpenes provide the 
distinguishing bouquet of the cannabis 
flower and can be used to phylogenetically 
classify cannabis strains. In fact, terpenes can 
make up three to five percent of the dry 
mass of cannabis flower.
Terpenes interact with receptors in 
our bodies to elicit responses, including 
at the neuroexcitatory dopaminergic and 
GABAergic receptors; beta-caryophyllene 
actually binds to the same CB1 receptor as 
THC (you may not know that cannabinoids 
are technically terpenoids – modified 
terpenes). Terpenes have shown many 
of the same properties associated with 
cannabinoids, including, analgesic, anxiolytic, 
anticancer, neuroprotective, and more. 
Up until recently, everyone has 
been fixated solely on THC content. 
Terpenes were not only being lost during 
processing but also in the discussion! It’s 
time for this to change.
How does the supply chain impact the 
quality of flower and therefore terpenes? 
Terpenes are volatile, so their 
preservation in cannabis flower 
post-harvest can be problematic. If the 
environmental conditions under which the 
cannabis flower is cured and stored are not 
optimal, terpenes will be lost, which changes 
the original terpenoid profile of that particular 
lot of cannabis flower. The extraction process 
can further reduce or eliminate terpenes.
How can we make sure research materials 
are kept in the best possible conditions–
and why should we care?
Put simply, cannabis research materials 
should be harvested, dried, and cured 
following a standard operating procedure 
(SOP). SOPs should also be followed 
after curing—cannabis flower should be 
stored under constant temperature and 
humidity conditions.
Stability of active ingredient(s) 
in any test material is essential. 
Furthermore, any active ingredient that is 
being studied in vitro or at the sub-clinical/
clinical level must be proven to remain stable 
for the duration of the study at a minimum 
but hopefully for much longer.
What are the critical control points 
in cannabis research that are being 
overlooked?
The number one priority has been to get 
the DEA to allow experienced cannabis 
growers to produce flower destined for 
research, following SOPs. We have seen 
progress, however; in 2021, the DEA offered 
some flexibility on who can grow cannabis 
flower for research purposes.  Labs such as 
Biopharmaceutical Research Company and 
other federally compliant organizations are 
working hard to ensure investigators are 
getting the best possible materials.
A Clever Primer  
on Quality Control
A rapid-fire interview with Andres 
Fajardo, President of Clever Leaves
How would accurate shelf-life claims 
of cannabis inflorescence benefit the 
industry as a whole?
Perhaps the biggest impact would be on 
patients and researchers, who would 
both have a better understanding of a 
critical aspect of product quality, which 
affects both safety and efficacy.
How critical is product stability to 
investigative outcomes?
The simple reality is that product 
characteristics can change over time. 
Characteristics are driven by chemical 
components, which can be subject 
to degradation. The loss of a key 
characteristic could result in a failure to 
deliver the desired effect (efficacy) or 
even pose a risk to the health of patients 
(safety). From a research perspective 
(for the reasons mentioned above), it is 
not possible to enter into an informed 
decision-making process without product 
stability knowledge. After all, instability 
of the product directly affects the 
reproducibility of the results, which harms 
the investigative process or the credibility 
of the outcome–or both.
How can we make sure research 
materials are kept in the best possible 
condition? 
As with medicines destined for patients, 
packaging should be considered 
a fundamental part of product 
development as it guarantees the stability 
of research materials. An important (but 
often overlooked) aspect of product 
development is the consideration of 
conditions throughout the whole chain. 
Good packaging along with modern 
technology, such as conditions tracking, 
supports this goal.
In short, the best way to keep any 
material in its optimal condition is 
by defining the storage and handling 
conditions–and these are related to the 
production process and the packaging.
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f you’d have told Jason Quinn two years ago that he was 
going to publish a paper on cannabis, he’d have laughed. 
Quinn is an Associate Professor in Mechanical 
Engineering and Director of the Sustainability Research 
Laboratory, Colorado State University, USA, specializing in the 
techno-economic assessment and economic viability of emerging 
energy-based systems – but here he is, writing about cannabis (1).
“I’m an improv guy; I always say yes,” Quinn laughs. 
“Someone asks ‘Do you want to look at converting mining 
trucks to hybrid electric or hydrogen vehicles?’ and I say yes. 
Do I know anything about it? Not a damn thing – but I’m 
excited to find out!” 
One day, someone came to Quinn with an idea: how about 
running an algal-based biofuel operation with solar panels and 
LED lights. Quinn said it would never work. “You cannot 
beat the sun. Plus, the sun is free – and free is good.” It doesn’t 
take an energy specialist to work out that converting light 
into electricity and back into light has all the hallmarks of 
inefficiency. But the very radical notion got Quinn thinking 
about indoor cannabis grows. How could converting coal power 
into photons with an efficiency of 2 percent – and delivering 
that to a plant with an efficiency of 2 percent at best be anything 
but bad for the environment? “The impact has to be huge – and 
that’s where the idea for the study came from. Evan Mills had 
already shown it wasn’t good and we wanted to see if we could 
take it to the next level.”
T H E 
C A N N A B I S 
C A R B O N 
B O M B
W h y  A m e r i c a ’ s  f r i e n d l y  n e i g h b o r h o o d 






Quinn, along with two of his PhD students, Hailey Summers 
and Evan Sproul, analyzed the energy and materials required 
to grow cannabis indoors and quantified the corresponding 
greenhouse gas (GHG) emissions using life cycle assessment 
methodology for a cradle-to-gate system boundary. Their 
analysis accounted for geographic variations and electrical grid 
emissions data. 
A $13.6 billion industry – and, as it turns out, a whole lot 
of emissions. Depending on location, GHG emissions ranged 
by as much as 200 percent, with cannabis grown in Southern 
California having the lowest emissions, at 143 pounds of carbon 
dioxide equivalent per ounce, while eastern O’ahu, Hawaii, had 
the highest at 324 pounds of carbon dioxide equivalent per ounce 
– the equivalent of burning 16 gallons of gasoline.
Across all locations, the biggest contributors to GHG emissions 
were heating, ventilation, and air conditioning (HVAC) systems 
required to maintain indoor temperature and humidity, as well as 
high-intensity grow lights and the supply of CO2, which accounts 
for 11–25 percent of facilities’ greenhouse gas emissions alone.
The results of the study confirm – perhaps unsurprisingly – 
that cultivating cannabis indoors leads to considerable GHG 
emissions – no matter where it is grown in the country. But the 
study doesn’t capture the full picture. “The CO2 measured here are 
just procurement emissions – the fact you have to take waste CO2 
from an ammonia plant, compress it into a bottle, and transport 
that bottle to the facility. Any CO2 that doesn’t get used is not 
attributed to the cannabis facility, it’s attributed to the ammonia 
facility – but the emissions associated with getting it from A to B 
are atrocious,” explains Quinn.
Y o u  s m o k e d  h o w  m u c h ? 
L e t ’ s  t a l k  s e r v i n g s
Quinn and his team make the conscious decision to publish 
emissions based on individual serving size – one tenth of a gram. 
“When reports say between two and five tons of CO2 equivalent 
per kilogram of dried flower you are too concerned about who in 
their right mind is consuming a kilogram of dried flower to focus 
on what that actually means. Showing emissions based on single 
serving grounds everybody.” 
With servings in mind, indoor cannabis cultivation comes out 
worse (in terms of GHG emissions) – between 0.73 and 1.66 
pounds of CO2 – than beer (0.63), wine (0.54), coffee (0.2), and 
spirits (0.08). And cigarettes, ironically, come out best of all (0.02).
Quinn offers an aside: “When I show this to my students I 
have to say, ‘Please don’t go home and tell your parents that your 
professor said you should smoke cigarettes. That’s not what I’m 
saying here.’” He stresses the data is an average and does not 
account for a 70-year-old who smokes two packs of cigarettes a 
day and is being treated for lung problems in hospital, with all the 
associated emissions...
In any case, herein lies the problem in granular detail. The 
solution, however, has not changed since Evan Mills published his 
first paper in 2021. Grow outdoors. Quinn and his team calculate 
that moving outdoors reduces GHG emissions by roughly 80 
percent. Make that a greenhouse – even with lights – and emissions 
still go down by 75 percent. “People say ‘Well, there are security 
issues with that’ but there are security issues with indoor grow 
facilities as well.” 
Has the work been met with any other criticism? “Many people 
have asked why we aren’t considering illegal cannabis cultivation 
– either the people growing cannabis in their basements or the 
larger networks of facilities,” says Quinn. “The truth is there is 
really no way for us to quantify the GHG emissions associated with 
that. But let’s be real, the amount of land used for illegal cannabis 
cultivation systems cannot be equivalent to more mainstream 
agricultural systems. Interestingly, one of the biggest challenges 
we had with this study is understanding how much legal cannabis 
is actually being cultivated inside, because there isn’t even a lot 
of good data on that.” The next step is getting data on outdoor 
greenhouse facilities and outdoor grow facilities to establish a 
precise figure on energy reduction. “We want to be able to say: here 
are the emissions from an indoor facility, here are the emissions 
from an outdoor grow facility. Please, make good choices.” 
I c e - c o l d  c a n n a b i s
But one issue with the cold-hard facts is that they are not one-
size-fits-all. Cannabis production cannot be treated as a monolith, 
when geography is the biggest variable impacting emissions for 
better or worse. In fact, it is impossible to read the paper without 
thinking that some areas shouldn’t be growing cannabis at all. 
“ M O V I N G 
O U T D O O R S  R E D U C E S 
G H G  E M I S S I O N S 
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“Northern Minnesota is not an ideal place to grow a tropical plant 
indoors or outdoors. It’s not rocket science,” says Quinn. “Southern 
California, on the other hand, is perfect. It has a temperate climate 
that doesn’t require the same indoor air controls as North Dakota. 
But you can’t cultivate in Southern California and then transport to 
Minnesota because you’re not allowed to cross state lines.”
The elephant in the room: federal illegality. Does it matter 
if people make better choices on an individual level without 
statewide federal change? Quinn remains hopeful: “Cultivators 
need to start incorporating energy efficiency requirements into 
their grow facilities as states legalize.”
But in the eagerness to legalize, there has been a whirlwind centred 
around the core issue, with very little thought about the energy impact 
and emissions. Even now, there remains little-to-no regulation on 
emissions from indoor cannabis grows. And perhaps it doesn’t help 
that the first policies following legalization pushed cultivators towards 
indoor grow facilities. “Some of the policies were crazy,” says Quinn. 
“In Colorado, for example, your grow facility had to be co-located 
with your dispensary. Where do people want to buy it? In downtown 
Denver – so that’s where they put the indoor grow facility.”
Understandably, the shift away from indoor cultivation will be 
simpler for some than others. But what about states that have already 
legalized? What can existing growers do – outside of switching to 
outdoor cultivation – to become more sustainable? “The answer is 
geographically specific,” says Quinn. “In the US, we run off grid 
energy and some grids are cleaner than others. One way of 
dramatically reducing your emissions is to switch to a more 
renewable energy source – I even know of one company who 
does their own on-site.”
“I don’t think that there’s a silver bullet outside of switching to a 
cleaner energy source, which is really the lowest hanging fruit. All 
other suggestions will have a small positive impact but you’d need 
to do many of them together to get the same results you would from 
switching to renewable energy.”
T h e  c o l o r  o f  m o n e y  –  
a n d  c o n s u m e r s
“The real problem here is the markup the industry has on the 
product – it is so large that all businesses care about is the quality 
of the product and they’re willing to invest all their money into it, 
regardless of the impact. There’s no pressure for them to reduce 
their carbon footprint because they can afford to do it.” 
The irony is not lost on Quinn. “The funny thing is that if you 
reduce the greenhouse gas emissions, you reduce your energy 
consumption, which means you reduce your operational costs. 
Now all of a sudden, your product is cheaper, but that’s just lost 
in the noise. But consumers aren’t demanding that they change 
either, so brands aren’t trying to differentiate themselves through 
environmental impact either.”
Enter the second most important player in the cannabis market: 
the “green” consumer. “I find it funny that you’ve got people 
rolling a joint, saying ‘Let’s save the planet, man!’ and I’m like, 
‘If you want to save the planet, you shouldn’t be smoking indoor 
Figure 1. Places with more extreme 
temperatures and fewer renewable energy 
sources have highest GHG emissions.
Credit: H Summers et al., “The greenhouse gas emissions 
 of indoor cannabis production in the United States”, 
Nature Sustainability, 644–650 (2021).
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cannabis, you should be drinking a beer!’” quips Quinn. “People 
should start thinking about choices they’re making in terms of the 
environment. The cannabis sector contributes a nontrivial percentage 
of a state’s total greenhouse gas emissions – and consumers have an 
opportunity to start making personal choices that are good for the 
planet. Just like taking your own grocery bags to the store – it’s a 
small thing that you can do for the planet.”
Promisingly, there is already a little change in the right direction. 
“Life cycle assessment and carbon accounting is becoming really big, 
especially among start-ups. My hope is that, as the industry continues 
to grow, brands will look for ways to differentiate themselves by 
becoming low carbon.” And that’s a particular easy win for up-and-
coming cannabis extractors who don’t need to factor in the role of 
consumer appeal: “People think the flower needs to look this way or 
that – but if you’re extracting THC for edibles, nobody cares what 
the flower looks like; that should be greenhouse or outdoor grown.” 
As states and countries legalize, Quinn hopes cultivators, 
regulators, and consumers consider some of the aspects mentioned in 
the paper as a part of the rollout plan: “Grow it outdoors in Southern 
California and ship it elsewhere. Let’s not have an indoor grow facility 
in Fairbanks, Alaska.” 
But having seen what happened following the Mills paper (not 
very much), Quinn has his doubts. “What’s frustrating for me is 
that, when the paper gets published, there’s a whirlwind of interest, 
and then nothing happens,” says Quinn. “I wasn’t expecting the 
world to change overnight but I do want to see some impact of 
our work.” He pauses, “I suppose it’s the same as investing money; 
you’ve got to give it a year to see the dividends. Will anybody 
actually make a change?” 
Let’s give it a year and see. 
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Evan Mills has been writing about climate change for 40 years. 
He participated in the work of the Nobel-Prize-winning 
Intergovernmental Panel on Climate Change and is a former 
Senior Scientist at the US Department of Energy’s Lawrence 
Berkeley National Laboratory, where he is now an affiliate. His 
specialty? Energy analysis – specifically the efficiency of energy 
use as the number-one strategy for addressing climate change. 
In 2012, he conducted a study that aimed to quantify a 
previously undocumented component of energy demand in the 
US – and to establish baseline impacts in terms of energy use, 
costs, and greenhouse-gas emissions in the cannabis industry. 
Mills observed, as is the case in many other areas of the economy, 
that many reversible inefficiencies are embedded in current 
practices. The ultimate area of inefficiency? Indoor cultivation. 
Indoor facilities contain lighting as intense as that found in an 
operating room (500-times more than needed for reading), six-
times the air-change rate of a biotech laboratory and 60-times 
that of a home. In short, it requires the electric power intensity 
of a data center. He writes that “large-scale industrialized and 
highly energy-intensive indoor cultivation of cannabis is driven 
by criminalization, pursuit of security, and the desire for greater 
process control and yields. The practice occurs across the United 
States and in many other countries.” 
With the yearly greenhouse-gas pollution from the electricity, 
plus associated transportation fuels, equaling that of 3 million 
cars, its annual energy bill was close to $6 billion at the time 
of the original study. In his latest article for Medium (one of 
hundreds that Mills has written over the last decade), he calls 
indoor cultivation “an unaffordable luxury in a warming world.”
We spoke to him to find out what’s changed, what hasn’t, and 
why not.
H o w  d i d  y o u  c o m e  t o  s t u d y 
i n d o o r  c u l t i v a t i o n ? 
About ten years ago, I was innocently shopping at a local 
nursery and noticed a row of 1000-watt lamps behind the 
counter, fans, ducting, CO2 canisters, the whole shebang. I 
started asking questions about the technology and standard 
practices. I built a spreadsheet model of facility energy use 
and one thing led to another. The proprietor of that store, 
Scott Zeramby, had a healthy combination of conscience, 
knowledge, and curiosity and helped me understand the 
industry and real-world practices. He collaborated with me 
on our upcoming publication.
H a v e  t h i n g s  g o t t e n  b e t t e r 
o r  w o r s e  s i n c e  t h e  s t u d y 
y o u  p u b l i s h e d  i n  2 0 1 2 ?
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Sadly, by most measures they have gotten far worse. There is actually 
little evidence of reductions in carbon-intensity (greenhouse-gas 
emissions per unit weight yield), despite the gradual introduction of 
LED lights, which people tend to regard as a panacea. I think there 
have been countervailing trends, such as increased illumination 
levels, more mechanization, more voluminous facilities, and 
wider aisles (requiring heating, cooling, and dehumidifying), and 
increased carbon dioxide injection. Meanwhile, there is far more 
indoor production in aggregate than previous years, so the total 
carbon footprint is no doubt growing. There was a lot of hope 
for misnamed “green” houses, but the reality is that they have 
incredibly energy-inefficient envelopes and still use a lot of artificial 
lighting, ventilation, and natural gas for heating, with the result 
that carbon intensity is only 25 percent lower than windowless 
warehouse facilities, according to published data.
I s  y o u r  w o r k  b e i n g  m e t 
d i f f e r e n t l y  n o w  t h a t 
c l i m a t e  b r e a k d o w n  
i s  m o r e  v i s i b l e ? 
There has been a lot of discussion and appreciation of the work since 
the beginning – though that, of course, is a far cry from change in 
actual practices. That said, a number of growers have contacted me 
over the years saying they’ve shifted operations outdoors, in part 
due to what they learned from my publications. There was never 
any serious push-back on the work. It took High Times five years 
to raise some questions, and it was kind of embarrassing for them, 
since their points were mostly erroneous (some outrageously so) 
or were strawman arguments attempting to shift the conversation 
away from the industry. They also aligned themselves with long-
since-debunked misinformation from the fossil fuel industry. It 
was kind of like Big Tobacco saying cigarettes are healthy for 
you. They really missed an opportunity to take a constructive 
leadership posture on the issue. As I  wrote to them at the time, I 
have no bias against the cannabis industry, safe recreational use, 
or legitimate medical applications of its products, but do have a 
strong bias against excessive avoidable energy use and associated 
greenhouse gases, wherever they can be found. 
Marijuana is hardly being singled out here. On 
the contrary, it has had a free ride for decades 
while all other energy uses have had to 
come into the 21st century.
“ T H E  C A N N A B I S 
S E C T O R 
C O N T R I B U T E S 
A  N O N T R I V I A L 
P E R C E N T A G E  O F 
A  S T A T E ’ S  T O T A L 
G R E E N H O U S E 
G A S  E M I S S I O N S  – 
A N D  C O N S U M E R S 
H A V E  A N 
O P P O R T U N I T Y  T O 
S T A R T  M A K I N G 
P E R S O N A L  C H O I C E S 
T H A T  A R E  G O O D 
F O R  T H E 
P L A N E T . ”
C o u l d  y o u  e x p l a i n  t h e 
c o n c e p t  o f  “ e m b e d d e d ” 
e n e r g y  u s e ? 
There is a widespread practice of quantifying the energy and carbon 
embedded (sometimes people say “embodied”) in the making of 
stuff – for example, the packaging, transportation, and storage 
energy use associated with a quart of milk. For cannabis, this would 
include growing media, fertilizers, industrial CO2 for injection into 
the growing space, carbon content of failed crops, and equipment 
manufacture. As one example, the very popular mineral-wool 
growing media is made by essentially melting rock (often with 
coal). This is a one-and-done product, with no recycling or other 
re-use. In our new study, we estimate that a 100ksf indoor grow 
would use 85,000 to 200,000 cubic feet of mineral wool per year 
(which goes to landfill), bumping the overall carbon footprint by 5 
percent to 11 percent, depending on your assumptions.
In their recent study, Jason Quinn, Hailey Summers and Evan 
Sproul analyzed the impact of the energy and carbon embodied in 
waste, transportation, injected CO2 and some agricultural inputs in 
some detail and found the inclusion of embedded energy to make 
a non-trivial contribution to the overall carbon footprint: it ranged 
almost 50 percent in milder climates to about 20 percent in more 
severe climates where relative energy use was greater.
There is also a parallel consideration of embedded water. Few 
people realize that it takes a lot of water to produce electricity. Those 
giant, iconic hourglass-shaped towers condense and cool a thermal 
power plant’s exit water so that it can be safely reintroduced to the 
environment (rivers and oceans). Even more water per unit of energy 
output is evaporated from behind hydroelectric dams. Water is also 
needed for the routine washing of solar arrays. When considering 
this “hidden” use, it turns out that it takes far more water to grow 
cannabis indoors than outdoors. This is yet another inconvenient 
truth about indoor cultivation.
W h y  a r e  p o l i c y m a k e r s  s o 
r e l u c t a n t  t o  a d d r e s s  t h i s 
c a n n a b i s  c a r b o n  b o m b ?  
It’s an enigma, but my theories are that it is a combination 
of ignorance, being co-opted, and political 
inconvenience. Few policymakers have 
the patience to really understand energy 
systems, and, increasingly, even fewer are 
willing to take an unpopular position 
of concern about cannabis cultivation 
practices. I think people are wooed 
and/or wowed by all the bling of 
indoor cultivation. (The indoor 
industry unashamedly uses women in bathing suits to sell lighting 
equipment and such…) The industry is much better organized 
and moneyed than the sungrowers, and has a more aggressive 
and sophisticated lobbying presence. I think there is also a 
problem with local government, which is hungry for the sales-
tax revenue, and the only way to get that is to keep cannabis 
cultivation within the city limits – which of course generally 
necessitates indoor cultivation because of land prices and odor-
control considerations. And energy companies (often referred to 
as “20-percent partners” by growers who pay that proportion of 
their revenues for electricity) want the increased revenue, even 
though in other quarters they talk a good line about promoting 
climate solutions. I’ve even been (quite) disappointed with my 
own colleagues who are so exuberant about energy efficiency that 
they can’t see that doing this in the particular case of cannabis 
is only optimizing the suboptimal. Meanwhile, environmental 
groups probably feel they would be in a bind by coming out against 
(indoor) cannabis, which many of their subscribers imbibe in and 
identify with in the increasingly blurred association with cannabis, 
nature, and green values.
A t  w h a t  p o i n t  d i d  c a n n a b i s 
a n d  e n v i r o n m e n t a l i s m 
d i v e r g e ?
Cannabis was more or less synonymous with the social 
and intellectual movements of the 1960s: mind expansion, 
interconnected, the earth and its resources are finite and need 
to be stewarded rather than squandered. Of course, some 
(perhaps many) cannabis cultivators and users likely still 
hold those good values, but there was a divergence first when 
cultivation moved indoors (requiring intensive energy use) and 
later as the industry became “big business.”  It’s important to 
say that, in parallel with this, many outdoor growers came to 
flaunt environmental values as well (illegal water diversions, 
use of illegal rodenticides, unpermitted road construction, for 
example). As is the case for almost all big businesses, profits and 
the game of skirting regulation often come before other goals. 
Though this is gradually improving through the environmental, 
social, and governance (ESG) movement, progress is 
slow and cannabis producers have not appeared 
in the vanguard. Most of the attention to 
sustainability among indoor producers 
does not get far beyond green-washing, 
with energy improvements limited 
to those that enhance profits and 
solar panels on the roof that look 
great but only meet a few percent 
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S o ,  w h o  s h o u l d  b e  l e a d i n g 
t h e  c h a r g e :  p r o d u c e r s , 
i n v e s t o r s ,  r e t a i l e r s , 
c o n s u m e r s ,  o r  p o l i c y m a k e r s ?
All of the above.
I s  t h e r e  a n y  o t h e r  c h a n g e 
t h a t  c o m e s  c l o s e  t o 
s w i t c h i n g  t o  o u t d o o r 
g r o w i n g  i n  t e r m s  o f 
e n v i r o n m e n t a l  g a i n s ?  
I’m afraid there is no viable alternative to outdoor cultivation. But the 
good news is that outdoor cultivation has helped people get high and 
healthy for 5,000 years. It’s like they say: if it ain’t broke, don’t fix it.
It would only take 0.01 percent of US farmland to meet all 
US cannabis needs outdoors. The only crop requiring less land 
today is birdseed.
I used to think that creating “net-zero” indoor facilities--with high 
efficiency and all energy provided by solar panels--was the way to go. 
But, I later found that zeroing-out carbon emissions would require 
vastly more capital investment than this industry or its investors would 
tolerate. To provide all electricity needs for a typical grow requires 
around twenty times the building’s land area in solar panel coverage, 
which is clearly a non-starter as well. I don’t see that waiting decades 
for the grid to be clean is appropriate either, as there are many, many 
other electric loads that have no outdoor alternative that need to be 
first in line. Also, there are impacts of centralized renewable energy 
production and transmission, so we need to always optimize and 
minimize energy demand first before producing energy, be it with 
coal plants or wind turbines.
D o  y o u  t h i n k  y o u ’ l l  s e e 
p o s i t i v e  c h a n g e  i n  t h e 
c a n n a b i s  i n d u s t r y  w i t h i n 
y o u r  l i f e t i m e ?
I’m certainly hopeful, but there is no real indication that this is 
happening – or that the industry or policymakers are taking it 
seriously enough. Rather, we’re seeing a lot of green-washing 
by this industry and willful ignorance by policymakers 
(local, state, and national). On the rare occasion when an 
indoor grower contacts me and says, “Hey, we’re running our 
operation with no carbon emissions,” I congratulate them, ask 
for the data, and then never hear from them again.
W h a t  h a s  t o  h a p p e n  f o r 
i n d u s t r y  t o  t a k e  g r e e n h o u s e 
g a s  e m i s s i o n s  m o r e  s e r i o u s l y ?
In decades of work on climate policy, we have massive 
evidence that free markets don’t, on their own, properly 
value environmental costs. This is often because of market 
imperfections and distortions.Regulation is usually needed to 
resolve market failures. I think the only option for policymakers 
is to require that all cannabis cultivation occur outdoors (and, of 
course, follow sustainable practices). This makes it incumbent on 
them to remove disincentives (for example, subsidies to indoor 
growers for LED lights that just make unsubsidized sungrown 
less competitive)and barriers (for example, the interstate 
transport issue – growing indoors in Long Beach requires half 
the energy as growing in Anchorage). As for the industry itself, 
I think there needs to be an effort to dispel the mythology 
about the inferiority of sungrown cannabis. If best-practices are 
pursued, subsidies or favoritism to indoor cultivators stopped, 
and the tendency of indoor retailers to undermine the reputation 
of sungrown is curbed, the straight economics will ultimately show 
that outdoor can be the most profitable strategy.
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W E L C O M E  T O 
C A L I F O R N I A
H o w  h i s t o r y  a n d  p o l i c y  i s 
s h a p i n g  c a n n a b i s  c u l t i v a t i o n 
i n  t h e  G o l d e n  S t a t e 
The focus of the Berkeley Cannabis Research Center is cultivation; 
namely, understanding how cannabis is grown, the environmental 
consequences of these practices, and how social, economic, and 
regulatory forces influence grower behavior and corresponding 
environmental impacts. Ted Grantham is Co-Director of the 
Center and Assistant Cooperative Extension Specialist at UC 
Berkeley’s Environmental Science, Policy and Management 
department. Here, he touches on how cannabis agriculture in 
California is evolving, as well as the burdens placed on growers 
seeking to enter California’s legal market.
H a s  c o n s e r v a t i o n  a l w a y s 
b e e n  p a r t  o f  t h e  c a n n a b i s 
c o n v e r s a t i o n ? 
Discussions around cannabis’ environmental impact are nothing 
new. California has had a long history of cultivation, starting in 
the 1960s, but accelerating in the mid-90s with an explosion of 
medical marijuana farms that preceded statewide legalization. With 
this significant growth of cannabis in North Coast region came 
environmental harms. After California voters approved the Adult 
Use of Marijuana Act under Prop 64 in 2016, the state developed 
a legal framework for regulating cannabis cultivation that was 
oriented towards minimizing potential environmental impacts, 
especially to wildlife and water resources. Less attention was given 
to greenhouse gas emissions associated with indoor cultivation. 
I s  t h e r e  a  r e a s o n  f o r  t h a t ?
Most of California’s cannabis is grown in outdoor and greenhouse 
settings and state regulations were focused on these types of 
operations, which have relatively low energy demands. Though 
there are certainly large indoor facilities, historically, they have 
been a smaller contributor to the market than in other states which 
do not share our climate. But one of the ironies of establishing 
stringent regulations around outdoor cultivation is that it may 
actually incentivize indoor production, which aren’t subject to 
the same requirements. For example, indoor production often 
occurs in facilities that are tied into municipal water supplies, 
whereas outdoor cultivators tend rely on groundwater and surface 
water local to meet their irrigation needs. Withdrawals from these 
natural water sources are subject to regulations that municipal 
sources are not and meeting these requirements can be quite 
difficult and expensive. If indoor production continues to expand 
in California, a lot more attention should be given to greenhouse 
gas emissions from cannabis cultivation.
H o w  d o  t h e  e n v i r o n m e n t a l 
i m p a c t s  o f  c a n n a b i s 
c o m p a r e  t o  o t h e r  c r o p s ?
One of the most important distinctions is scale. The footprint of 
cannabis is actually very small compared to that of most other 
agricultural crops. The average farm size in northern California 
is about a quarter of an acre. In comparison to wine grapes, for 
example, which are grown in vineyards that often span hundreds 
of acres, cannabis farms are quite small. Now consider agriculture 
in California. Statewide, we have around 9 million acres under 
irrigated agricultural production – a fraction of one percent of that 
footprint is occupied by cannabis. But, the reason we are concerned 
about cannabis impacts has everything to do with where it is grown. 
Unlike most other agriculture in the state, which mostly occurs in 
large valleys, cannabis farms are concentrated in remote, upland 
watersheds, which is a consequence of decades of prohibition. 
Because of their location, cannabis farms tend to be in closer 
proximity to wildland areas, where impacts to fish and wildlife 
are more likely to occur. Though cannabis isn’t a particularly thirsty 
crop (despite how it’s portrayed in popular media coverage), we also 
have concerns about the water usage because supplies are naturally 
limited in the watersheds where farms are located. So even though 
water demand for a cannabis farm is low, relative to other crops, 
withdrawals can still have a big impact on streams and other 
ecologically sensitive habitats. 
H o w  i s  B e r k e l e y ’ s  C a n n a b i s 
R e s e a r c h  C e n t e r  e n g a g i n g 
w i t h  t h e s e  i s s u e s ?
First and foremost, we are conducting research to establish a 
foundation of knowledge around cannabis cultivation practices and 
environmental impacts. Prior to legalization, it was quite difficult 
to conduct cannabis research and it’s remarkable how few scientific 
studies have been conducted on cannabis agriculture. We’ve also 
been working to bring the regulatory community – the agencies 
responsible for issuing permits – and the grower community 
together, using scientific information to facilitate conversations 
around cannabis policy. These conversations are complicated by the 
fraught history between government law enforcement and growers. 
Understandably there is distrust on both sides. But if we want a 
successful legal market for 
cannabis, this relationship 
needs to be rebuilt.
We are particularly interested 
in lowering unnecessary barriers 
to participation in the legal system. 
Despite being two or three years into 
the legalization program, the vast majority 
of cannabis growers in California do not have permits. 
We believe legal operations represent less than a quarter of the 
operations that exist statewide. So we still have a long way 
to go in the transition into a fully-legal market. There are 
some growers that will inevitably remain in the black market, 
but there are likely many more that would otherwise enter if 
regulations were streamlined.
C o u l d  y o u  e x p l a i n  w h a t 
m a k e s  t h e  r e g u l a t o r y 
p r o c e s s  d i f f i c u l t ?
The difficulty lies in the way the law is structured. Though 
there is a statewide framework for issuing permits, the law 
has a local control provision which means every county must 
develop a local ordinance to allow for cannabis cultivation. 
Currently, fewer than half the counties in the state have those 
ordinances, which effectively means it is still illegal to grow 
cannabis in half the state. So even if growers were interested in 
entering the legal market, they cannot until a local ordinance 
is established. 
Another key issue is cost. To get a permit, you are required 
to make infrastructure upgrades, for example, by redesigning 
your facility to minimize the risk of sediment runoff from 
roads and farm operations. This can cost upwards of $100,000. 
The permits themselves can also be quite expensive, not to 
mention the administrative burden that many growers are not 
necessarily equipped to navigate. Because growers have long 
operated at the fringes of society, permitting can be a foreign 
and challenging bureaucratic process.
W h e n  y o u  s p e a k  t o 
g r o w e r s ,  a r e  t h e y  g e n e r a l l y 
r e c e p t i v e  t o  t h e s e  k i n d s  o f 
c o n v e r s a t i o n s ? 
Growers – at least the ones we speak to – are generally very 
supportive of our work. They view our research as helping to 
legitimize cannabis as an agricultural commodity, rather than 
an illicit drug. The stigma against cannabis growers is still quite 
prevalent; many people don’t consider its cultivation a legitimate 
economic enterprise. However, most 
growers see themselves as farmers – not 
dissimilar to a grower of wine grapes who 
creates a product that is extremely valuable 
though arguably non-essential. 
S p e a k i n g  o f  c a n n a b i s  a s 
a n  a g r i c u l t u r a l  p r o d u c t ; 
h o w  d o e s  i t s  c u l t i v a t i o n 
s t a n d a r d s  c o m p a r e  w i t h  t h o s e 
o f  o t h e r  c r o p s ? 
Most people are not aware that California’s agricultural regulations 
are actually much more stringent for cannabis than for other crops. 
There are strict standards for cannabis cultivation practices that set 
requirements around the use of fertilizers, pesticides and water 
use, and limit the size and location of farms. And then there is the 
extremely rigorous testing processes (for heavy metals, pesticides, 
and contaminants) that go far beyond what’s required for other 
crops. As there is still uncertainty around the human health impacts 
of consuming trace chemicals on cannabis, the state took a very 
conservative approach in setting thresholds. Whether warranted or 
not, from a grower’s perspective, the burdens are much greater for 
cannabis than other crops. Of course, it is important to distinguish 
between growers who have received permits and comply with these 
regulations, and the vast majority of growers, who still operate on 
the black market and are unlikely to follow the same practices. 
W h a t  c a n  w e  d o  t o  s u p p o r t 
e n v i r o n m e n t a l l y  s u s t a i n a b l e 
c a n n a b i s  p r o d u c t i o n ? 
Policies need to address barriers to compliance, especially the costs 
for infrastructure upgrades to satisfy permit requirements. The 
problem is that many of the federal programs designed to support 
other agricultural crops, through incentives such as matching 
funds, aren’t available to cannabis growers. These programs need 
to be revised or the state needs to develop analogous programs 
that will provide more support for growers who currently don’t 
have access to the resources needed to make the site improvements 
needed to obtain permits.
The fact also remains that, as long as cannabis is federally illegal, 
there will continue to be strong incentives for illegal growers. And 
that’s because the black market is primarily supported by interstate 
commerce (illegal product crosses state lines to places where it 
will get a better price). Until cannabis is legalized at the federal 
level – effectively undercutting the black market – the state will 
struggle to bring growers into compliance. And the environment 
will continue to suffer. 
www.thecannabisscientist.com
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W A T E R 
T O  W I N E 
M e e t  t h e  c o m p a n y 
c h a l l e n g i n g  t h e  c o n c e p t  o f 
w a s t e  w i t h  a  m i c r o b e - b a s e d 
p r o c e s s  t h a t  c o n v e r t s  o r g a n i c 
m a t e r i a l  i n t o  f e r t i l i z e r
Charles Smith, co-founder and CEO of Full Circle Microbes, 
is a self-confessed optimist. Smith believes that people working 
together can overcome any challenge. And, in this case, the 
challenge is waste – lots of it. The agricultural industry generates 
nearly 24 percent of global greenhouse gas emissions (GHG) – 
and treats a significant portion of each crop as waste. Smith and 
his co-founders found a way to help farmers and the environment 
by turning wasted organic material that harms the planet into 
sustainable fertilizer that helps it. Here, he tells us how. 
W h a t  i s  F u l l  C i r c l e 
M i c r o b e s  d o i n g  t o  t a c k l e 
t h e  e n v i r o n m e n t a l  i m p a c t 
o f  c a n n a b i s  c u l t i v a t i o n ?
We started Full Circle Microbes to address the environmental 
issues associated with wasting organic matter – and in 
recognition that there is great value potential in things that are 
treated as waste. Farms often produce organic “waste” in the 
same location that plants need to consume nutrients, making 
it a very natural fit for our on-site organics recycling process. 
In developing microbial inoculants that turn crop-residuals 
into bioavailable nutrients through on-farm recycling, we 
allow farmers to keep valuable nutrients where they’re needed, 
improving their financial and environmental outlook.
H o w  c a n  o r g a n i c  w a s t e 
h e l p  w i t h  o u r  i n d o o r  g r o w 
p r o b l e m ? 
Recycling organic waste on-site allows growers to reduce their 
reliance on nutrients and Ag chemicals that they ship to their 
location, reducing emissions in three key ways. 
Less fertilizer consumption: synthetic nitrogen fertilizer is 
commonly made through the Haber-Bosch process – an extremely 
energy intensive approach to artificial nitrogen fixation that often 
relies on natural gas feedstocks that are sourced through fracking. 
Recapturing the nitrogen contained 
in the cannabis stalk and introducing 
beneficial microbes offers a much more 
environmentally-friendly alternative.
Reduce emissions from transportation of nutrients 
and offsite disposal: recapturing nutrients with on-site 
recycling and using less fertilizer means fewer trucks are 
required to transport fertilizer and therefore less GHG emissions 
from hauling. Similarly, avoiding the need to dispose of wasted 
organic matter offsite eliminates transportation emissions.
Eliminate emissions from incineration and improper disposal: 
some growers currently incinerate their leftover plant matter, 
releasing GHG emissions as smoke. Others render their wasted 
plant matter unusable and send it to the landfill, where organic 
matter often breaks down anaerobically, generating methane 
gas which is ~28 times more potent than carbon dioxide as a 
greenhouse gas. 
Our research partners at University of Vermont recently 
generated data showing that recycling cannabis biomass with 
our inoculant also has pathogen suppressive effects, which can 
help growers reduce their reliance on chemical options that can 
be harmful to ecological and human health. 
H o w  d o  y o u  t r a n s f o r m 
h a r m f u l  w a s t e  i n t o  v a l u a b l e 
n u t r i e n t s ?
Organic matter becomes harmful waste when it’s improperly disposed 
of in landfills and burn piles. The key to our organics recycling 
process is the microbial inoculant we’ve developed to efficiently turn 
leftover plant matter into a fertilizer substitute within 3–5 weeks. 
Whereas traditional composting relies on input balance and ongoing 
maintenance (watering and turning piles) in an effort to indirectly 
cultivate the microbial communities needed for organics recycling, 
our approach directly introduces the microbial communities that we 
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“ T H E R E ’ S  A  M Y T H 
T H A T  H E L P I N G 
T H E  E N V I R O N M E N T 
M E A N S  H U R T I N G 
Y O U R  B U S I N E S S , 
B U T  T H I S 
A B S O L U T E L Y  D O E S 
N O T  N E E D  T O  B E 
T H E  C A S E . ”
Salt precisely balances moisture by creating a TERPENE SHIELD
know are most effective in recycling organic matter.
Our inoculant contains microbes that break down lignin, cellulose, 
and hemicellulose, the plant fibers that give the stalks its structure, but 
also shield the nutrients within it after the plant is harvested. Breaking 
through these tough polymers creates nutrient access, which is then 
increased by microbes that produce organic acids to further enhance 
nutrient bioavailability. Finally, our inoculant contains microbes that 
form beneficial relationships with the next generation of the plant 
and facilitate efficient nutrient uptake once the recycled biomass is 
reincorporated into the growth substrate. 
Our inoculant can be applied to chipped up stalks and plant 
residuals either in a pile or a container – whichever works best 
for the individual grow.
W h a t  a r e  y o u r  t h o u g h t s 
o n  c a n n a b i s ’  i m p a c t  o n 
t h e  e n v i r o n m e n t  m o r e 
g e n e r a l l y ? 
I think the attention being paid to environmental issues with 
cannabis and the fact that many industry participants and 
consumers care very much about sustainability bodes well for 
positive changes in the industry. The research by Hailey M. 
Summers, Evan Sproul and Jason C. Quinn at Colorado State 
University is very important in understanding where things 
currently stand – and the need for action. As noted in their 
paper, certain regulatory and industry factors have pushed 
cultivation indoors, where huge amounts of energy are needed 
for lighting, HVAC, and other aspects of indoor cultivation. 
I believe many cultivators would welcome the opportunity to 
generate this energy through alternative energy sources, and I 
know of some growers that have been able to implement solar 
energy, Powerwalls, and geothermal power to fully supply 
their cultivation sites without fossil fuels. I’m hopeful that 
industry dynamics, regulatory updates, and consumer preferences 
for sustainability will all help to move the industry in a more 
environmentally-friendly direction. 
D o  y o u  f e e l  h o p e f u l  t h a t 
t h e  i n d u s t r y  c a n  a n d  w i l l 
b e c o m e  m o r e  s u s t a i n a b l e ?
I do feel hopeful, as I see both a need and desire for increased 
sustainability. The recent IPCC report shows overwhelming 
data that every industry needs to immediately work to reduce 
GHG. As a relatively young industry, I hope that cannabis will 
respond quickly to incorporating environmentalism into its 
foundation as it continues to grow. I also believe that consumers 
of cannabis products tend to be environmentally conscious and 
that consumer preferences will reward cultivators that produce 
a high-quality product in an environmentally-friendly way.
W h a t  n e e d s  t o  h a p p e n  f o r 
t h e  i n d u s t r y  t o  a d o p t  m o r e 
e a r t h - f r i e n d l y  p r o c e s s e s ?
Many cannabis cultivators want to be sustainable and there are 
several factors that can help push the industry in that direction. 
The first is continued innovation. Our technology allows growers 
to increase sellable yields, while reducing nutrient costs and 
becoming more sustainable. There’s a myth that helping the 
environment means hurting your business, but this absolutely 
does not need to be the case. The second is consumer preference. 
Cannabis consumers tend to care about the environment, and I 
believe we’ll see an increasing preference for sustainable practices 
as the industry matures and brand recognition increases. The 
third is a regulatory focus on sustainability. I am seeing regulatory 
entities paying more attention to the environmental impact of 
their policies and I’m hopeful that sustainable production can 
become a key tenant of future regulatory frameworks.
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HPLC Method to  
Differentiate Four THC 
Stereoisomers Formed 
From Δ9-THC Degradation 
 
Discover a robust, chiral HPLC stationary phase 
method to separate Δ10-THC and Δ6a,10a-THC 
isomers produced from Δ9-THC degradation
By Jeffrey B. Williams, Kathleen B. Calati, Kirk W. Hering, 
Roxanne E. Franckowski, Weston J. Umstead and Donna M. Iula
Degradation of Δ9-THC to Δ10-THC and Δ6a,10a-THC isomers 
provides a challenging separation in Cannabis-derived products. 
The use of an immobilized cellulose chiral column under normal-
phase liquid chromatography conditions provides an analytical 
method to fully separate these four THC isomers for identification 
and accurate determination of potency.
As the primary phytocannabinoid associated with psychoactive 
properties, Δ9-THC is crucial to the determination of 
potency for extracts, edibles, and other Cannabis-derived 
products. The additional processing required for providing 
these Cannabis products may result in their degradation, 
forming isomers that can be misidentified and provide invalid 
potency claims. Δ9-THC can isomerize to two diastereomers, 
(6aR,9S)-Δ10-THC and (6aR,9R)-Δ10-THC. These two 
distinct stereoisomers may undergo additional isomerization 
to form a pair of enantiomers, providing 9(S)-Δ6a,10a-THC 
and 9(R)-Δ6a,10a-THC, respectively (Figure 1). 
The stereochemical similarities between the Δ10-THC and 
Δ6a,10a-THC isomers are particularly challenging to fully 
resolve under typical reversed-phase liquid chromatography. 
Additionally, the Δ6a,10a-THC enantiomers are not separable 
without the use of a chiral stationary phase.
A chiral column under normal-phase liquid chromatography 
(NPLC) conditions fully separated these THC isomers 
(Figure 2). Chiral column CHIRALPAK® IB N-3 (250 x 
4.6 mm, 3 µm) under NPLC conditions, controlled at 30°C, 
was used. Elution was accomplished with mobile phase 95:5 
Hexane:Isopropyl Alcohol (IPA) at 0.85 ml/min for 15 
minutes. A 1 µl injection of a 1 mg/ml solution in IPA was 
monitored at 228 nm. The neat materials were formulated 
into certified reference material (CRM) solutions. To provide 
CRMs with optimal stability, each of the solutions were 
prepared as a 1 mg/ml solution in acetonitrile. Although 
acetonitrile and hexane are immiscible, the inclusion of IPA 
to the mobile phase maintains the baseline resolution of the 
analytes despite the diluent. This method may be used to 
develop testing methods to resolve and accurately quantify 











Figure 1. Isomerization of Δ9-THC under first basic (OH-) and then acidic 
(H+) conditions can lead to several structurally similar isomers
Figure 2. A co-injection of all four isomers in acetonitrile with the NPLC method
Instrument Agilent 1100 Series
Column CHIRALPAK
® IB N-3 (250 x 
4.6 mm, 3 µm) 
Mobile Phase A: 95:5 Hexane:Isopropyl 
Alcohol
Flow Rate 0.85 ml/min
Column Temp. 30°C
Wavelength UV monitored at 228 nm
































Removes more moisture per 30-amp breaker
than any dehumidifier on the market—besting
the closest competitor by more than 40%
The industry’s first
Variable-speed, Low Grain 
Refrigerant dehumidifier!   
HIGH CAPACITY.  MAXIMIZES VPD.
OPTIMIZED FOR LATE FLOWER.
A710 HIGH-CAPACITY, GROW-OPTIMIZED
DEHUMIDIFIER WITH PATENT PENDING
PINTS
P E R  D AY
710
#BUILTFORGROW
800-972-3710  |  ANDEN.COM
Introducing the QuEChERS method for the simultaneous 
analysis of cannabis for 47 pesticides, 5 mycotoxins and 3 
cannabinoids. Most of the LC-MS/MS amenable compounds 
on the Massachusetts and Nevada monitoring lists of 
pesticides and mycotoxins are included within the application 
note. Sample purification is carried out using UCT’s cleanup 
product SpinFiltr™, which combines the convenience of 
classical dispersive-SPE (dSPE) with an ultrafiltration tube 
containing a 0.2 µm filter membrane to simultaneously remove 
unwanted matrix components and filter the sample prior to LC 
or GC analysis. The SpinFiltr™ dSPE tube uses PSA, C18 
and ChloroFiltr® sorbents for sample cleanup. ChloroFiltr® 
is a unique polymeric sorbent designed for the removal of 
chlorophyll and, unlike graphitized carbon black (GCB), does 
not result in the loss of planar analytes. Liquid chromatography, 
using a Selectra® Aqueous C18 column, coupled to tandem mass 
spectrometry (LC-MS/MS) is used for analysis of the pesticides, 
mycotoxins and cannabinoids.
View Application Note: https://bit.ly/3BR13IT
Analysis of Pesticide 
Residues, Mycotoxins and 

























Figure 1: Chromatogram showing extracted sample of pesticides at 5ng/ml
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Technology
PIC Solution Turnkey Hemp/Cannabis 
Extraction and Purification 
Our unique “One Machine – Multiple Use” systems are 
designed for both CO2 extraction (SFE) and purification 
(SFC). Our instruments enable automated stepwise 
extraction of terpenes and cannabinoids, eliminate the 
need for winterization, automate Hemp remediation, 
isolate individual cannabinoids and remove impurities to 
produce safe and compliant natural ingredients.
For more information visit: https://www.pic-sfc.com/
PRO-MIX® CONNECT™
The most concentrated mycorrhizal 
inoculant! Use PRO-MIX® CONNECT™ 
as a slurry when transplanting your 
rooted plants for a quick connection and 
to establish a strong symbiosis to develop 
a secondary root system improving water 
and nutrients uptake. The results? More 
yield, increased cannabinoid content and 
enhanced terpene profile. 
Learn more at https://bit.ly/promixconnect
Streamline cannabis testing 
with CGM LABDAQ, the 
leading LIMS software
CGM LABDAQ lab management 
software streamlines cannabis testing with 
data management, instrument integration, 
support of multi-step protocols, quality 
control, inventory management, and 
more. CGM LABDAQ is supported by 
CompuGroup Medical, a global leader in 
eHealth with offices in 18 countries and 
1.6 million users worldwide.
Learn more at www.cgmcannabis.com 
SpinFiltr® dSPE  
SpinFiltr® combines conventional dSPE 
with the added benefit of ultrafiltration. 
UCT’s format of dSPE sorbents paired with 
a 0.2 µm filtration device, simultaneously 
removes unwanted matrix compounds and 
filters samples without the need for any 
additional steps. SpinFiltr® allows analysts 
to recover additional samples without the 
salts getting in the way.
For more information, visit unitedchem.com
Dr (No) Pain 
Sitting Down With… Mikael Sodergren, Managing Director & 
Academic Lead, Sapphire Medical Clinics, Research Director, 
EMMAC Life Sciences, Consultant Hepatopancreatobiliary Surgeon 
and Honorary Senior Clinical Lecturer, Imperial College London, UK.
www.thecannabisscientist.com
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What did you want to be when you 
were growing up?
I wanted to be a cowboy until I was six or 
seven. After that, a tennis professional. Then, 
when I was 16, I settled on being a doctor. 
Now, I’m pretty happy but always intrigued 
what life as a cowboy would be like.
So how did you end up in cannabis?
I’m a surgeon by training. One day a 
week, I do operations on complex cancers of 
the pancreas and liver. The natural extension 
to that clinical interest was research around 
(pancreatic) cancer biology. In 2018, the 
Nobel Prize was awarded for cancer 
immunotherapy and we suddenly realized 
we’d been barking up the wrong tree. The 
real prize in the treatment of cancer is to 
focus not on the cancer cells, but on the 
immune system.
After that, I became involved with 
looking at ways we can modulate the 
immune system, which is how I stumbled 
across CBD – a very effective anti-
inflammatory. At the time, it hadn’t been 
mapped out on a scientific level in relation to 
cancer biology. We could see the therapeutic 
benefit in combining CBD with cytotoxic 
chemotherapies for pancreatic cancer – we 
just didn’t know how. It was a black box.
Eventually, we secured funding for 
the Imperial College Medical Cannabis 
Research Group, which I now lead. 
As well as cancer biology, we research 
another of my clinical interests: pain. As a 
surgeon, I unfortunately cause people pain 
by default – a short-term disadvantage we 
try to address in surgery. We’ve been trying 
to move away from systemic opioids, 
which have negative effects on respiratory 
function and predispose patients to chest 
infections, ultimately keeping them in 
hospital longer. Cannabis is a promising 
alternative. 
Where does Sapphire Medical Clinics 
come into this?
My colleagues and I set up Sapphire 
Medical Clinics around the time the 
law changed, almost as an extension of 
our research. Having established what 
cannabis can (and can’t) do naturally 
leads to one of two things: either 
conducting clinical trials for marked 
authorization or prescribing medicines 
under certain circumstances off-label. 
We saw a really interesting opportunity 
in collecting that data so that we could 
help eliminate the medical cannabis 
knowledge gap and, ultimately, allow 
more people to access these medicines 
for free on the NHS.
Is it frustrating to know that medical 
cannabis is legal, but still so difficult 
to access?
It’s heartbreaking to see patients who 
obviously derive great benefit from the 
medications, but can’t access them for 
free like other treatments on the NHS. 
But at the same time, I can see how 
it has happened. We have a system in 
place in the UK in which we undertake 
cost-effectiveness analysis to establish 
whether taxpayers are prepared to foot 
the bill on a population level for certain 
medicines. I don’t think cannabis should 
be treated any differently. 
What are the barriers to getting data 
on this scale? 
Funding is obviously key. We need 
everyone – policymakers, regulators, 
medical professionals, academics – to 
sing from the same hymn sheet to work 
out these compounds’ medical uses. 
That requires short-term solutions. 
One of the positive things in the UK 
is that NIHR, a major funding body, 
has designated calls for research into 
cannabis-based medicinesh. Despite 
that, we haven’t seen any large-scale 
randomized controlled trials, in part 
because they are so expensive. We need 
to prioritize and accelerate this, because 
we urgently need to resolve the mismatch 
between our knowledge and patients 
seeking treatment.
Why hasn’t it happened yet?
It goes without saying that the pandemic 
has slowed things down. Clinical 
research was essentially put on hold 
for a year. But a group effort almost 
certainly requires national infrastructure. 
Hopefully, in this post-Brexit era, more 
resources at a government level will be 
dedicated to these kinds of initiatives 
between industry and academia.
Do you think the rise in popularity of 
CBD is helping or hindering medical 
cannabis advocacy efforts?
A bit of both. It’s certainly not helpful to 
read tabloid articles claiming that CBD 
cures everything under the sun (because it 
doesn’t), but it clearly highlights the fact that 
we need to understand CBD better. Public 
perception is distorted by the fact that not 
only can a doctor prescribe CBD, but you 
can also buy it on the high street. So is it a 
medicine or not? 
Can you tell us more about your own 
research activities?
We’re doing some really interesting work 
on pain, essentially trying to untangle the 
spaghetti of different compounds present in 
the plant. Right now, we’re looking at three 
individual cannabinoids and seeing how, 
when combined in different proportions and 
doses, they create an analgesic effect (or not).
So far, we’ve been able to decrease 
the dose of THC by adding another 
cannabinoid without reducing the analgesic 
effect in vitro. I’m excited to develop that 
research further, and hopefully translate 
it to human studies soon.
If you weren’t doing this, what would 
you be doing?
I’d be involved in drug development for 
cancer with immunotherapies. I still hope 
that I will someday cure cancer – but, 
although there are lots of people working 
on immunotherapy at the moment, there 
are far fewer looking to plug the gaps in our 
understanding of medical cannabis.
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advancing the science of cannabis.
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